Search - tctmd.com

Displaying 21 - 40 of 161

Sort: Relevancy | Date

News Daily News

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Yael L. Maxwell

July 22, 2016

News Daily News

Decline Seen in Readmissions After PCI in the Medicare Population

Todd Neale

July 21, 2016

News Industry News

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

June 17, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

Presentation Fellows 2016

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Roxana Mehran

April 15, 2016

News Daily News

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

Michael O'Riordan

March 31, 2016

News Opinion Editor's Corner

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

Shelley Wood

March 28, 2016

News Daily News

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

Yael L. Maxwell

January 25, 2016

News Daily News

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

Yael L. Maxwell

January 25, 2016

News Daily News

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

Yael L. Maxwell

January 25, 2016

News Daily News

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Yael L. Maxwell

December 22, 2015

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

News Daily News

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Yael L. Maxwell

December 22, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

In-hospital Mortality Higher When IABPs Deployed During PCI

Todd Neale

November 04, 2015

Presentation TCT 2015

TCT 77: Risk and Benefits of Triple Therapy in Patients Undergoing Percutaneous Coronary Stent Implantation Requiring Chronic Oral Anticoagulation A Meta-analysis of 12 Trials

Presenter: Lisa K. Jennings, Neal S. Kleiman, Lucia Barbieri

October 13, 2015

Presentation TCT 2015

PCI and Atrial Fibrillation Anticoagulation: Triple or Dual Therapy?

Presenter: George D. Dangas, Paul A. Gurbel, C. Michael Gibson

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Daily News

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

August 04, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

Advertisement

High Rates of Upper GI Bleeding After TAVR Pose Questions for Antithrombotics and TEE

Decline Seen in Readmissions After PCI in the Medicare Population

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Most Patients Undergoing Diagnostic Angiography Before Noncardiac Surgery Are Asymptomatic

ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More

心动过缓与不良结局相关，但只有在服用影响心率的药物时才成立

La Bradicardia se asocia a Resultados Adversos pero Solo Con Fármacos Modificadores de la Frecuencia Cardíaca

Bradycardia Linked to Adverse Outcomes, But Only in Conjunction With Heart Rate-Modifying Drugs

三联疗法特别是普拉格雷会增加急性心梗患者的出血风险

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

El Tratamiento Triple, sobre todo con Prasugrel, Aumenta el Riesgo Hemorrágico de los IAM

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

In-hospital Mortality Higher When IABPs Deployed During PCI

TCT 77: Risk and Benefits of Triple Therapy in Patients Undergoing Percutaneous Coronary Stent Implantation Requiring Chronic Oral Anticoagulation A Meta-analysis of 12 Trials

PCI and Atrial Fibrillation Anticoagulation: Triple or Dual Therapy?

Discussion Highlights Merits, Limitations of Small Trials

年长房颤 PCI 患者在接受三联疗法时，其血栓状况未得到改善，且出血事件增加

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content